Explore how integrated collaboration among specialists is reshaping the psoriatic arthritis care pathway and optimizing ...

A multinational study shed light on which sites to scan for early signs of the disease, but scoring system was less sensitive ...

Ultrasound-based phenotyping distinguishes inflammatory and non-inflammatory forms of difficult-to-treat psoriatic arthritis, ...

Several racial and ethnic groups were significantly underrepresented in pivotal psoriatic arthritis trials performed between ...

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

Health experts reveal the impact of the inflammatory skin condition on joints, and highlight symptoms and management tips ...

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

As second-line therapy for PsA and axSpA, no clear treatment-retention benefit at 3 years was seen when swapping to a bDMARD with another MOA.

More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older ...

Morning stiffness may seem harmless, but when it lasts longer than half an hour, it can be an early sign for conditions like ...

Glenmark Pharmaceuticals Limited has received approval from the Subject Expert Committee (SEC), functioning under the Central ...